Topiramate-induced psychotic exacerbation: case report and review of literature (Q38221155)

31 August 2017

Topiramate-induced psychotic exacerbation: case report and review of literature (English)

1 reference

31 August 2017

0 references

1 reference

Ersin Hatice Karslioğlu

1

1 reference

31 August 2017

Hande Karakiliç

2

1 reference

31 August 2017

Ender Taner

3

1 reference

31 August 2017

Behçet Coşar

4

1 reference

31 August 2017

1 January 2007

1 reference

International Journal of Psychiatry in Clinical Practice

31 August 2017

1 reference

31 August 2017

11

1 reference

31 August 2017

4

1 reference

31 August 2017

285-290

1 reference

Drug treatment of epilepsy in the 1990s. Achievements and new developments.

31 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

Use of topiramate, a new anti-epileptic as a mood stabilizer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

Topiramate antagonizes MK-801 in an animal model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

Adjuvant topiramate administration: a pharmacologic strategy for addressing NMDA receptor hypofunction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

Open-label adjunctive topiramate in the treatment of bipolar disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

Confusion and dysphoria with low-dose topiramate in a patient with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

Is topiramate effective for weight loss in neuroleptic-induced obesity? 2 case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

Acute psychotic symptoms induced by topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

Depression in epilepsy: a common but often unrecognized comorbid malady

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

Schizophrenia-like psychosis and epilepsy: the status of the association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

Topiramate improves deficit symptoms in a patient with schizophrenia when added to a stable regimen of antipsychotic medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic case-series outcome study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

Evidence of glutamatergic deficiency in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

Topiramate-induced psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

Topiramate for refractory schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

The importance of being seizure free: topiramate and psychopathology in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

A revised excitotoxic hypothesis of schizophrenia: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

Acute psychotic disorders induced by topiramate: report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500601117215

10.1080/13651500601117215

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference